RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers
A new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially important biomarker and therapeutic target across gastrointestinal cancers.
Read original article on The Medical News →Related news
-
Stem cell–like tumor state may help identify high-risk small-cell lung cancer
-
Novel study explores how different types of genetic risk impact the manifestation of alcohol use disorder
-
Conventional diagnostic tools overlook gaming disorder in female players
-
Adidas Sweeps the 2026 Chicago Marathon: Here Are the Shoes Worn by the Fastest Runners
-
The 5 Best Rain Jackets That’ll Keep You Dry and on Pace
-
More active mitochondria may help chronic myeloid leukemia cells withstand treatment
-
15-Minute Yin Yoga to Support Your Mental Endurance
-
Low levels of blood pressure protein may flag treatment-resistant psychosis